Mirae Asset Global ETFs Holdings
LUCD icon

Mirae Asset Global ETFs Holdings’s Lucid Diagnostics LUCD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.3K Buy
68,471
+25,591
+60% +$27.6K ﹤0.01% 2950
2026
Q1 		$49.3K Buy
42,880
+1,020
+2% +$1.3K ﹤0.01% 2906
2025
Q4 		$45.6K Buy
41,860
+9,997
+31% +$11.2K ﹤0.01% 2954
2025
Q3 		$32.2K Sell
31,863
-5,905
-16% -$6.45K ﹤0.01% 3010
2025
Q2 		$43.4K Buy
+37,768
New +$48.8K ﹤0.01% 2909

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LUCD Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Lucid Diagnostics (LUCD) stake by 60% in Q2 2026, buying an estimated $27.6K and bringing the position to 68,471 shares worth $73.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2950.

Mirae Asset Global ETFs Holdings first reported a position in LUCD in Q2 2025 and has held it in 5 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 68,471 shares of Lucid Diagnostics worth $73.3K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 25,591 Lucid Diagnostics shares in Q2 2026, an estimated $27.6K.
  • Lucid Diagnostics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2950 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Lucid Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.